Diabetes Care Advances: LEVEMIR Drug Insight and 2032 Market Forecast Revealed
24 janv. 2024 10h50 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LEVEMIR Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The healthcare industry has taken a...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
09 janv. 2024 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...
Global Glucagon-like Peptide 1 (GLP-1) Market Soars to $18.75 Billion by 2023, Fueled by Increasing Healthcare Expenditure and Aging Population
10 nov. 2023 08h48 HE
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of...
Diabetes Drugs Market Size to Surpass USD 134.08 Billion by 2030, exhibiting a CAGR of 7.8%
25 oct. 2023 07h15 HE
|
Fortune Business Insights
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The global diabetes drugs market size was valued at USD 66.15 billion in 2022, and it is expected to expand from USD 79.25 billion in 2023 to USD...
Global Diabetes Epidemic: Unprecedented Economic Burden of $966 Billion in 2021 Underscores Urgency for Innovative Therapeutics and Diagnostics
18 sept. 2023 07h38 HE
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Diabetes Therapeutics and Diagnostics" report has been added to ResearchAndMarkets.com's offering. The latest market analysis...
Continuous Development of GLP-1 Agonists Drives Dominance in the Diabetes Drug Market
11 août 2023 07h58 HE
|
Research and Markets
Dublin, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The "Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Diabetes Assays Pipeline Analysis Report 2023: Stages of Development, Segments, Territory, Regulatory Path and Key Companies
28 juin 2023 05h33 HE
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report...
United Kingdom Diabetes Market Research Report 2023: A $7.77 Billion Market by 2028 - Industry Trends, Growth, Impact of Inflation, Forecasts, Opportunities, Company Analysis
30 mars 2023 09h48 HE
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been...
Sweden Diabetes Market Report 2023: Featuring B. Braun Melsungen, Eli Lilly, Novo Nardisk, Becton, Dickinson, Medtronic & More
07 mars 2023 06h23 HE
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "Sweden Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to...
Global Diabetes Care Drugs Market to Reach $103 Billion by 2027: Asia-Pacific is Poised to Show a Considerable Growth Rate
06 mars 2023 09h48 HE
|
Research and Markets
Dublin, March 06, 2023 (GLOBE NEWSWIRE) -- The "Global Diabetes Care Drugs Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The global diabetes care...